Rare Home Infusion And Specialty Nursing Agency – Kansas City Metro
Asking Price: $575,000 | 10+ Years Operating | Specialty-Nursing License
This is a rare opportunity to acquire a well-established home infusion and specialty nursing agency with a proven, niche business model that is difficult to replicate and faces virtually no direct competition.
Founded in 2015, this agency specializes in in-home chemotherapy, immunotherapy, and complex infusion treatments, serving patients throughout the Kansas City metropolitan area and surrounding regions within a two-hour radius. Patients consistently choose this service over hospital-based infusion centers, resulting in exceptionally high satisfaction and loyalty.
Why This Business Stands Out:
Specialty-Nursing License with custom-built policies and procedures
Highly differentiated niche not commonly offered in most U.S. markets
10 years of operational history with strong physician and patient relationships
Scalable model that can be replicated across additional regions and states
No direct competition due to the complexity and regulatory barriers
Core Services:
In-home chemotherapy & specialty infusions
Immunotherapy, IVIG, iron, monoclonal treatments
At-home blood draws & lab coordination
Follow-up care, medications, IV fluids, and physician reporting
Operational Highlights:
Administrative office in Lenexa, KS with medication inventory
Negative-pressure mixing equipment in place
Accepts most major insurances, including Medicare & Medicaid
Works with multiple specialty pharmacy suppliers
Growth Opportunity:
This business is optimized, proven, and ready to scale. The operational framework and licensing structure allow for:
Expansion into new territories
Increased patient volume through physician outreach
Replication of the model in additional states
Transition And Support:
The seller is retiring and is committed to a smooth transition, offering up to six months of hands-on support to ensure continuity and long-term success.
Ideal for:
Healthcare operators, strategic buyers, infusion centers, or investors seeking a defensible, high-barrier healthcare business with long-term growth potential.
